RJF vs TVTX · rev $15.91B vs rev $296.8M
RJF (RJF) versus Travere Therapeutics Inc (TVTX) — a side-by-side from cached financials, not a winner call.
RJF (RJF) common stock.
Travere Therapeutics Inc (TVTX) is a biotechnology company listed on US.
Latest reported RJF revenue for 2025-09-30 was $15.91B. Net income was $2.13B. Revenue was up 6.6% from 2024-09-30 to 2025-09-30. RJF currently screens at market cap $0.
Latest reported TVTX revenue for 2026-06-30 was $296.8M. Net income was -$71.9M. TVTX currently screens at market cap $1.33B.
RJF currently screens at market cap $0. TVTX currently screens at market cap $1.33B.
Not investment advice. Open the RJF and TVTX stock pages for the full models.
Not investment advice.